Dissociation kinetics and avidity gate SARS-CoV-2 neutralization by HR2 stem helix antibodies
SARS-CoV-2 evolution has reduced the efficacy of clinical monoclonal antibodies, underscoring the need for therapeutics targeting conserved viral regions. The Spike (S) heptad repeat 2 (HR2) stem helix is highly conserved across SARS-CoV-2 variants and related betacoronaviruses. Although antibodies to this region can neutralize infection, their natural occurrence and evolution remain poorly…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.